These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33529425)

  • 21. Single-cell RNA sequencing highlights the immunosuppression of IDO1
    Zhang Y; Zhang J; Zhao S; Xu Y; Huang Y; Liu S; Su P; Wang C; Li Y; Li H; Yang P; Yang C
    Theranostics; 2024; 14(12):4787-4805. PubMed ID: 39239507
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
    Fu J; Su Y; Liu Y; Zhang XY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic potential of Type VII Collagen during oral carcinogenesis.
    Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S
    J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
    Tarle M; Müller D; Raguž M; Lukšić I
    Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia].
    Xue JY; Zhu XY; Wei CL; Sun P; Zhang H; Deng J
    Shanghai Kou Qiang Yi Xue; 2021 Apr; 30(2):201-205. PubMed ID: 34109363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
    Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
    J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.
    Shirasuna K; Hayashido Y; Sugiyama M; Yoshioka H; Matsuya T
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):349-53. PubMed ID: 2024456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of EGFR in prognostic characterization in histopathological variants of oral squamous cell carcinoma.
    Tyagi D; Singhal M; Gulati N; Jain A; Shetty DC
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S743-S746. PubMed ID: 38384049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Aurora kinase A suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo.
    Tanaka H; Nakashiro K; Iwamoto K; Tokuzen N; Fujita Y; Shirakawa R; Oka R; Goda H; Hamakawa H
    Oral Oncol; 2013 Jun; 49(6):551-9. PubMed ID: 23481312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
    Mehta A; Chowdhary M; Sinha R
    J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and Significance of Periostin in Tissues and Serum in Oral Leukoplakia and Squamous Cell Carcinoma.
    Guan WQ; Li Q; Ouyang QM
    Cancer Biother Radiopharm; 2019 Sep; 34(7):444-450. PubMed ID: 31170012
    [No Abstract]   [Full Text] [Related]  

  • 37. PD-1 blockade prevents the progression of oral carcinogenesis.
    Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
    Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
    He H; Sun G; Ping F
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic outcomes of oral squamous cell carcinoma derived from proliferative verrucous leukoplakia: A systematic review.
    Faustino ISP; de Pauli Paglioni M; de Almeida Mariz BAL; Normando AGC; Pérez-de-Oliveira ME; Georgaki M; Nikitakis NG; Vargas PA; Santos-Silva AR; Lopes MA
    Oral Dis; 2023 May; 29(4):1416-1431. PubMed ID: 35199416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
    Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
    Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.